1 in 25 Indians Carry a Gene Mutation That Causes Heart Failure

In India and other south Asian countries, one in 25 people carries a gene mutation that causes heart failure, a new research has found.

Loyola University Health System researcher Sakthivel Sadayappan, said that studying this gene, and the protein it encodes, could lead to new treatments for heart failure.

Quiz on Healthy Heart
Heart disease is a major killer worldwide in spite of major strides in the medical field in terms of research, diagnosis, treatment and pharmacology. HIV/AIDS and Alzheimer’s disease are vying for popular attention these days and people tend to sideline or neglect healthy heart awareness. Take our quiz and refresh your awareness on heart disease.

Sadayappan has studied the gene and protein for 15 years.

Investigating the protein could provide 'a better understanding of the mechanics of heart function during health and disease,' Sadayappan and first author David Barefield said.

Previous studies by Sadayappan and other researchers found that about 4 percent of people who live in India, Pakistan, Sri Lanka, Indonesia and Malaysia carry the mutation. Carriers have about a 90 percent chance of developing heart failure after age 45.

An Active Heart
The heart pumps blood constantly providing the power to sustain life.

About 60 million people worldwide, including about 40 million Indians, carry the mutation. (Sadayappan, who is from India, is not a carrier.) Sadayappan said the mutation likely arose in a single person roughly 33,000 years ago, and spread throughout south Asia.

The gene encodes for a protein, called cardiac myosin binding protein-C (cMyBP-C), that is critical for the normal functioning of the heart. In the mutated gene, 25 base pairs (DNA letters) are missing. As a result, the tail end of the protein is altered.

Top 11 Latest Facts & Figures on Heart Attacks
Heart attack usually occurs when a clot blocks the blood supply to the heart. If not treated, it can lead to death. Here are must know facts on heart attacks.

Due to this modification, the protein is not properly incorporated into the functioning unit of cardiac muscle called sarcomere. Consequently, the heart does not contract properly.

In younger carriers, the heart can compensate for this defect. But as the person ages, his or her heart is no longer able to compensate. Heart muscle becomes inflamed and does not work well, a condition called cardiomyopathy.

Congenital Heart Disease – Septal Defects
Heart diseases that are present at birth are called “ Congenital heart diseases”.

The most common manifestation of cardiomyopathy is heart failure-the heart can't pump enough blood to the rest of the body.

There is no current treatment to prevent heart failure in people who carry the mutated gene. However, a heart-healthy diet and exercise can delay the onset of heart failure, and heart failure drugs can manage symptoms.

Sadayappan said stem cell therapy could be a possible treatment. Stem cells would be taken from a patient's heart, genetically engineered to replace the mutated gene with a healthy gene, and then injected back in the patient's heart. But such stem cell therapy has not been tested. Nor is there a commercial test for the gene, Sadayappan said.

But Sadayappan and other scientists are actively researching how cMyBP-C functions. And improved understanding of this crucial protein, Sadayappan said, could lead to new drugs to treat heart failure.

The study has been published in the Journal of Molecular and Cellular Cardiology.

Source-ANI